NAFDAC selected the 600 pharmacists from all 36 states and the Federal Capital Territory (FCT).
The partnership will support Nigeria’s post-marketing vaccine surveillance system by evaluating innovative screening devices and expanding routine laboratory testing for vaccine lots.
The warning comes after an official report from Roche Nigeria, which traced the fake products bearing batch number N2110A09 in Kaduna and Gombe States.
The alert followed official communication from Roche Nigeria after the pharmaceutical company received multiple complaints from healthcare professionals nationwide.
The complaints originated from Lagos University Teaching Hospital (LUTH-NSIA), where patients brought in suspected counterfeit products for administration.
NAFDAC released the public alert following a Notice of Concern from the WHO Prequalification service.
NAFDAC’s decision came after assessing outcomes from these surgeries, which used the Toumai system manufactured by Shanghai MicroPort MedBot.